<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T00:43:59Z</responseDate>
  <request identifier="oai:figshare.com:article/34046028" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34046028</identifier>
        <datestamp>2026-10-01T13:26:26Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Exploration of newly synthesized sulfonohydrazides as potential enzyme inhibitors: synthesis, characterization, and &lt;i&gt;in silico&lt;/i&gt; studies</dc:title>
          <dc:creator>Lubabah Abdul Karim (25156683)</dc:creator>
          <dc:creator>Amara Mumtaz (7319555)</dc:creator>
          <dc:creator>Syeda Abida Ejaz (4816971)</dc:creator>
          <dc:creator>Tariq Ismail (43062)</dc:creator>
          <dc:creator>Abdul Mannan (4257871)</dc:creator>
          <dc:creator>Maria Siddique (13111938)</dc:creator>
          <dc:creator>Irum Shahzadi (10728630)</dc:creator>
          <dc:creator>Anam Shahzadi (12154209)</dc:creator>
          <dc:creator>Nighat Fatima (788832)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>Hydrazide</dc:subject>
          <dc:subject>sulfonohydrazide</dc:subject>
          <dc:subject>carbonic anhydrase-II</dc:subject>
          <dc:subject>15-lipoxygenase</dc:subject>
          <dc:subject>cholinesterases</dc:subject>
          <dc:subject>MD simulations</dc:subject>
          <dc:subject>ADME</dc:subject>
          <dc:subject>molecular docking</dc:subject>
          <dc:description>&lt;p&gt;To synthesize novel sulfonohydrazide derivatives and evaluate their physicochemical and enzyme‑inhibitory profiles, together with the corresponding structure–activity relationships.&lt;/p&gt; &lt;p&gt;A series of six hydrazide derivatives (NLs&lt;sub&gt;1&lt;/sub&gt;–NLs&lt;sub&gt;6&lt;/sub&gt;) was synthesized and subjected to comprehensive &lt;i&gt;in vitro&lt;/i&gt; enzymatic evaluation against four critical targets: 15-Lipoxygenase (15-LOX), Carbonic anhydrase II (β-CA-II), Butyrylcholinesterase (BChE), and Acetylcholinesterase (AChE). Furthermore, to determine the stability and binding of the synthesized compounds, molecular dynamic simulations and molecular docking were performed.&lt;/p&gt; &lt;p&gt;Bromo- and fluoro-substituted NLs&lt;sub&gt;2&lt;/sub&gt; (IC&lt;sub&gt;50&lt;/sub&gt; = 0.29 ± 0.02 µM) and NLs&lt;sub&gt;3&lt;/sub&gt; (IC&lt;sub&gt;50&lt;/sub&gt; = 0.54 ± 0.01 µM) showed significant activity against AChE. Furthermore, compound NLs&lt;sub&gt;4&lt;/sub&gt; demonstrated significant cholinesterase inhibitory activities, i.e. AChE and BChE, although the inhibitory potential against AChE (IC&lt;sub&gt;50&lt;/sub&gt; = 0.72 ± 0.11 µM) was comparatively higher than that of BChE (IC&lt;sub&gt;50&lt;/sub&gt; = 0.65 ± 0.03 µM). MD trajectories of all three systems involving proteins and NLs&lt;sub&gt;3&lt;/sub&gt; indicate that AChE-NLs&lt;sub&gt;3&lt;/sub&gt; exhibit the highest level of overall structural stability, closely followed by LOX-NLs&lt;sub&gt;3&lt;/sub&gt; as both have a low RMSD amplitude and low residue variations.&lt;/p&gt; &lt;p&gt;These findings identify several derivatives as promising multi-target lead compounds for the treatment of diseases driven by the dysregulation of lipid metabolism, cholinergic signaling, and carbonic anhydrase activity.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T13:26:26Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.34046028.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Exploration_of_newly_synthesized_sulfonohydrazides_as_potential_enzyme_inhibitors_synthesis_characterization_and_i_in_silico_i_studies/34046028</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
